Simply Put: AstraZeneca COVID-19 vaccine
Protection against COVID-19 infection, severe disease falls quickly after AstraZeneca 2nd dose: Lancet
Begins to wane after 18-19 weeks; study stresses on need for booster dose
COVID-19 vaccine update: People above 45 eligible for jabs from April 1
Ministry of Home Affairs releases updated guidelines for COVID-19 control
Pfizer withdraws application for Emergency Use Authorisation in India
The company will resubmit application after getting more data
Govt neither denies nor accepts adverse event in Serum Institute COVID-19 vaccine trial
Health secretary claims all procedures followed but refuses to divulge details
COVID-19: Next virus could be worse, AstraZeneca vaccine creator Sarah Gilbert says
Research that has not been peer reviewed says that Omicron may be more infectious, but not severe
COVID-19 vaccines: Did a delayed second dose give the delta variant an evolutionary helping hand?
Those with a single dose of the Pfizer or AstraZeneca vaccine less-protected than those with 2 doses: Public Health England
India readies for COVID-19 vaccination but vexed questions on the solution remain
The risks the country needs to prepare for, precautions it needs to take, the logistics required and, above all, the implications of it all for …
COVID-19: First few peer reviewed studies suggest vaccine induced antibodies fail to protect from Omicron
The studies, published in Nature, covered Oxford-AstraZeneca vaccine, but not India’s indigenous Covaxin
Oxford-AstraZeneca COVID-19 vaccine: What do WHO recommendations say
Health workers at high risk of exposure and older people — including those aged 65 or older — should be given priority for Oxford / …
COVID-19 vaccine update: AstraZeneca vaccinations should continue, benefits outweigh risks, says WHO
Strategic advisory group of experts on immunization called the one-dose Janssen shot as a safe and lifesaving addition to Pfizer, Moderna and …
COVID-19 vaccine update: South Africa may return Serum Institute of India doses
The WHO has approved the Oxford-AstraZeneca coronavirus jab for emergency use. This means the vaccine can be rolled out globally
COVID-19 vaccines for all: Decoding global tenders by states
At least a dozen Indian states have floated or will float tenders for procuring vaccines and will also bear the cost
Gujarat recipients gung-ho on COVID-19 vaccine
The state will vaccinate about 440,000 healthcare workers and 355,000 frontline workers in the first round
COVID-19 vaccine: Oxford-AstraZeneca up to 90% effective in late stage trial
Adenovirus vaccine can be stored at 2-8°C; company to apply for emergency authorisation
COVID-19 Challenge 2021: How does the world overcome vaccine shortage
The pharmaceuticals industry must come together to ensure all adults are vaccinated against the novel coronavirus; …
What COVID-19 vaccine side effects might I expect?
In the vast majority of cases, any side effect you feel will be over within a few days, and there is no reason for concern
UK, South African, Brazilian: A virologist explains each COVID-19 variant, what they mean for the pandemic
The take-home message is that variants will emerge, and we need to closely monitor their spread
DCGI clears Bharat Biotech, SII COVID-19 vaccines but efficacy question unanswered
CDSCO official says BB vaccine to be used in public but to exclude people with COVID-19, other infections
Decision on emergency authorisation for SII, Bharat Biotech’s COVID-19 vaccines deferred
Both manufacturers have been asked for more data before a final decision can be reached
Coronavirus update: AstraZeneca halts global vaccine trials
COVID-19 has affected 19 sectors in India that were not under stress earlier, with a total Rs 15.5 lakh crore outstanding debt; retail and …